Objectives: To present the case of a pregnant woman diagnosed with craniopharyngioma and to review the literature on the diagnosis, treatment, and maternal-perinatal outcomes of this type of tumor.
Material And Methods: A 41-year-old multigravida at 23.6 weeks of gestation was admitted to a high-complexity private clinic due to significant bilateral visual acuity reduction and headache. A diagnosis of craniopharyngioma was made, and expectant management was chosen. The patient underwent an uncomplicated cesarean delivery. The literature review included case reports and series on pregnant women diagnosed with craniopharyngioma. Literature was searched on PubMed, EBSCO, and Scopus, along with references from the selected studies. A narrative summary of the findings is provided.
Results: Ten case reports were included. All patients presented with visual disturbances, and eight cases had diabetes insipidus. Magnetic resonance imaging (MRI) was used in nine cases, effectively identifying the tumor. Seven patients underwent craniotomy (four during pregnancy, two postpartum, and one post-abortion), while three had transsphenoidal surgery (two during pregnancy and one postpartum). Three cases experienced tumor recurrence, and two had incomplete resection. During the postpartum period, 9 cases had resolution of visual symptoms. In four cases, follow-up ranged from two to six years without evidence of recurrence.
Conclusions: In pregnant women with bitemporal hemianopsia, a possible suprasellar tumor should be suspected. MRI of the brain and sella turcica is the diagnostic modality of choice. Further studies are needed to document this condition in pregnancy and its obstetric management in greater detail.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11812093 | PMC |
http://dx.doi.org/10.18597/rcog.4215 | DOI Listing |
Am J Obstet Gynecol
March 2025
Friends Research Institute, Baltimore, MD.
Pain management in pregnant and postpartum people with an opioid use disorder requires a balance among the risks associated with opioid tolerance, including withdrawal or return to opioid use, considerations around the social needs of the maternal-infant dyad, and the provision of adequate pain relief for the birth episode that is often characterized as the worst pain a person will experience in their lifetime. This multidisciplinary consensus statement from the Society for Obstetric Anesthesia and Perinatology, the Society for Maternal-Fetal Medicine, and the American Society of Regional Anesthesia and Pain Medicine provides a framework for pain management in obstetrical patients with opioid use disorder. The purpose of this consensus statement is to provide practical and evidence-based recommendations and is targeted to healthcare providers in obstetrics and anesthesiology.
View Article and Find Full Text PDFContraception
March 2025
Oregon Health and Science University 3181 SW Sam Jackson Park Rd, Portland, OR 97239 USA. Electronic address:
Objectives: The current study focuses on how abortion access affects people who are pregnant, have chronic kidney disease (CKD), and desire an abortion. From the perspective of the pregnant patient, we will examine the outcomes and costs associated with providing or refusing in-state access to abortion for this population.
Study Design: A decision-analytic model was built to compare the outcomes and costs associated with providing abortions in-state compared to those associated with a complete statewide abortion ban.
Drug Alcohol Depend
February 2025
Institute of Psychiatry and Neurology, Child and Adolescent Psychiatry Clinic, Warsaw, Poland. Electronic address:
Background: The standard of care for treating opioid use disorder (OUD) during pregnancy includes either buprenorphine or methadone. Although buprenorphine-naloxone presents an alternative due to the reduced risk of misuse , evidence regarding its impact on pregnancy and infant health remains limited. This systematic review and meta-analysis aims to compare buprenorphine-naloxone vs buprenorphine alone for OUD during pregnancy, assessing gestational and neonatal outcomes.
View Article and Find Full Text PDFWomens Health (Lond)
March 2025
Department of Laboratory Technology Science, School of Medicine, College of Medicine and Health Sciences, Dire Dawa University, Dire Dawa, Ethiopia.
Background: Adequate gestational weight gain affects birth outcomes and increases the risk of non-communicable diseases later in life. Weight gain in pregnant Ethiopian women with hyperemesis gravidarum has not been investigated comprehensively.
Objective: To assess the determinants of weight gain in pregnant women with hyperemesis gravida in Dire Dawa Administration, Eastern Ethiopia.
J Diabetes Sci Technol
March 2025
Medicine and Pediatrics, Barbara Davis Center for Diabetes, Adult Clinic, School of Medicine, University of Colorado Anschutz Medical Campus, Aurora, CO, USA.
Automated insulin delivery (AID) systems adapt insulin delivery via a predictive algorithm integrated with continuous glucose monitoring and an insulin pump. Automated insulin delivery has become standard of care for glycemic management of people with type 1 diabetes (T1D) outside pregnancy, leading to improvements in time in range, with lower risk for hypoglycemia and improved treatment satisfaction. The use of AID facilitates optimal preconception care, thus more women of reproductive age are becoming pregnant while using AID.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!